Literature DB >> 22088821

Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus.

Scott V Monte1, Joseph A Caruana, Husam Ghanim, Chang Ling Sia, Kelly Korzeniewski, Jerome J Schentag, Paresh Dandona.   

Abstract

BACKGROUND: Roux-en-Y gastric bypass (RYGB) results in profound weight loss and resolution of type 2 diabetes mellitus (T2DM). The mechanism of this remarkable transition remains poorly defined. It has been proposed that endotoxin (lipopolysaccharide [LPS]) sets inflammatory tone, triggers weight gain, and initiates T2DM. Because RYGB may diminish LPS from endogenous and exogenous sources, we hypothesized that LPS and the associated cascade of oxidative and inflammatory stress would diminish after RYGB.
METHODS: Fifteen adults with morbid obesity and T2DM undergoing RYGB were studied. After an overnight fast, a baseline blood sample was collected the morning of surgery and at 180 days to assess changes in glycemia, insulin resistance, LPS, mononuclear cell nuclear factor (NF)-κB binding and mRNA expression of CD14, TLR-2, TLR-4, and markers of inflammatory stress.
RESULTS: At 180 days after RYGB, subjects had a significant decrease in body mass index (52.1 ± 13.0 to 40.4 ± 11.1), plasma glucose (148 ± 8 to 101 ± 4 mg/dL), insulin (18.5 ± 2.2 mμU/mL to 8.6 ± 1.0 mμU/mL) and HOMA-IR (7.1 ± 1.1 to 2.1 ± 0.3). Plasma LPS significantly reduced by 20 ± 5% (0.567 ± 0.033 U/mL to 0.443 ± 0.022 E U/mL). NF-κB DNA binding decreased significantly by 21 ± 8%, whereas TLR-4, TLR-2, and CD-14 expression decreased significantly by 25 ± 9%, 42 ± 8%, and 27 ± 10%, respectively. Inflammatory mediators CRP, MMP-9, and MCP-1 decreased significantly by 47 ± 7% (10.7 ± 1.6 mg/L to 5.8 ± 1.0 mg/L), 15 ± 6% (492 ± 42 ng/mL to 356 ± 26 ng/mL) and 11 ± 4% (522 ± 35 ng/mL to 466 ± 35 ng/mL), respectively.
CONCLUSION: LPS, NF-κB DNA binding, TLR-4, TLR-2, and CD14 expression, CRP, MMP-9, and MCP-1 decreased significantly after RYGB. The mechanism underlying resolution of insulin resistance and T2DM after RYGB may be attributable, at least in part, to the reduction of endotoxemia and associated proinflammatory mediators. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22088821     DOI: 10.1016/j.surg.2011.09.038

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  52 in total

1.  Reduction in inflammation and the expression of amyloid precursor protein and other proteins related to Alzheimer's disease following gastric bypass surgery.

Authors:  Husam Ghanim; Scott V Monte; Chang Ling Sia; Sanaa Abuaysheh; Kelly Green; Joseph A Caruana; Paresh Dandona
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

2.  Changes in intestinal permeability after Roux-en-Y gastric bypass.

Authors:  Alexandre Lages Savassi-Rocha; Marco Túlio Costa Diniz; Eduardo Garcia Vilela; Maria de Fátima Haueisen Sander Diniz; Soraya Rodrigues de Almeida Sanches; Aloísio Sales da Cunha; Maria de Lourdes de Abreu Ferrari; Henrique Oswaldo da Gama Torres; Bruno Antonio Maciente; Gabriela Santana Ataliba; Paloma Maciel Araújo; Taciana Bretas Guerra; Inara Kellen Fonseca Balbino
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

Review 3.  Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Authors:  Jean Debédat; Chloé Amouyal; Judith Aron-Wisnewsky; Karine Clément
Journal:  Semin Immunopathol       Date:  2019-04-25       Impact factor: 9.623

4.  Dietary Polysaccharides in the Amelioration of Gut Microbiome Dysbiosis and Metabolic Diseases.

Authors:  Shokouh Ahmadi; Rabina Mainali; Ravinder Nagpal; Mahmoud Sheikh-Zeinoddin; Sabihe Soleimanian-Zad; Shaohua Wang; Gagan Deep; Santosh Kumar Mishra; Hariom Yadav
Journal:  Obes Control Ther       Date:  2017-12-18

5.  Sleeve Gastrectomy Alters Intestinal Permeability in Diet-Induced Obese Mice.

Authors:  Claire Blanchard; François Moreau; Julien Chevalier; Audrey Ayer; Damien Garcon; Lucie Arnaud; Jean-Paul Pais de Barros; Thomas Gautier; Michel Neunlist; Bertrand Cariou; Cédric Le May
Journal:  Obes Surg       Date:  2017-10       Impact factor: 4.129

Review 6.  Obesity and Altered Aspirin Pharmacology.

Authors:  Nicholas B Norgard
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

7.  Roux-en-Y Esophagojejunostomy Ameliorates Renal Function Through Reduction of Renal Inflammatory and Fibrotic Markers in Diabetic Nephropathy.

Authors:  Cuifang Wang; Bing He; Dongxu Piao; Ping Han
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

8.  Effects of sleeve gastrectomy and rs9930506 FTO variants on angiopoietin/Tie-2 system in fat expansion and M1 macrophages recruitment in morbidly obese subjects.

Authors:  Nicté Figueroa-Vega; Benjamín Jordán; Elva Leticia Pérez-Luque; Luis Parra-Laporte; Serafín Garnelo; Juan Manuel Malacara
Journal:  Endocrine       Date:  2016-08-31       Impact factor: 3.633

9.  Duodenojejunal Bypass Leads to Altered Gut Microbiota and Strengthened Epithelial Barriers in Rats.

Authors:  Po-Jen Yang; Wei-Shiung Yang; Hsiao-Ching Nien; Chiung-Nien Chen; Po-Huang Lee; Linda Chia-Hui Yu; Ming-Tsan Lin
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

10.  Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease.

Authors:  Ajay P Belgaumkar; Royce P Vincent; Kirstin A Carswell; Robin D Hughes; Jamie Alaghband-Zadeh; Ragai R Mitry; Carel W le Roux; Ameet G Patel
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.